French biotech building the first global database of cancer survivors to discover new cancer drugs.
| Date | Round | Amount |
|---|---|---|
| Mar 2024 | Seed Cure51 raised a EUR15M seed round led by Sofinnova Partners to build its global clinical and molecular database of cancer survivors. | $16.2M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.